These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11741704)

  • 1. A scintillation proximity assay for studying inhibitors of human tau protein kinase II/cdk5 using a 96-well format.
    Evans DB; Rank KB; Sharma SK
    J Biochem Biophys Methods; 2002 Jan; 50(2-3):151-61. PubMed ID: 11741704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II.
    Yamaguchi H; Ishiguro K; Uchida T; Takashima A; Lemere CA; Imahori K
    Acta Neuropathol; 1996 Sep; 92(3):232-41. PubMed ID: 8870824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A scintillation proximity assay for the Raf/MEK/ERK kinase cascade: high-throughput screening and identification of selective enzyme inhibitors.
    McDonald OB; Chen WJ; Ellis B; Hoffman C; Overton L; Rink M; Smith A; Marshall CJ; Wood ER
    Anal Biochem; 1999 Mar; 268(2):318-29. PubMed ID: 10075822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells.
    Zheng YL; Li BS; Amin ND; Albers W; Pant HC
    Eur J Biochem; 2002 Sep; 269(18):4427-34. PubMed ID: 12230554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of p56(lck) kinase activity using scintillation proximity assay in 384-well format and imaging proximity assay in 384- and 1536-well format.
    Beveridge M; Park YW; Hermes J; Marenghi A; Brophy G; Santos A
    J Biomol Screen; 2000 Aug; 5(4):205-12. PubMed ID: 10992041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk5 as a drug target for the treatment of Alzheimer's disease.
    Lau LF; Seymour PA; Sanner MA; Schachter JB
    J Mol Neurosci; 2002 Dec; 19(3):267-73. PubMed ID: 12540052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of neuronal cyclin-dependent kinase-5 by staurosporine and purine analogs is independent of activation by Munc-18.
    Veeranna ; Shetty KT; Amin N; Grant P; Albers RW; Pant HC
    Neurochem Res; 1996 May; 21(5):629-36. PubMed ID: 8726973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for cdk5 as a major activity phosphorylating tau protein in porcine brain extract.
    Hosoi T; Uchiyama M; Okumura E; Saito T; Ishiguro K; Uchida T; Okuyama A; Kishimoto T; Hisanaga S
    J Biochem; 1995 Apr; 117(4):741-9. PubMed ID: 7592534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
    Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
    Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.
    Pei JJ; Grundke-Iqbal I; Iqbal K; Bogdanovic N; Winblad B; Cowburn RF
    Brain Res; 1998 Jun; 797(2):267-77. PubMed ID: 9666145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.
    Sengupta A; Wu Q; Grundke-Iqbal I; Iqbal K; Singh TJ
    Mol Cell Biochem; 1997 Feb; 167(1-2):99-105. PubMed ID: 9059986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5.
    Baumann K; Mandelkow EM; Biernat J; Piwnica-Worms H; Mandelkow E
    FEBS Lett; 1993 Dec; 336(3):417-24. PubMed ID: 8282104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry.
    Lund ET; McKenna R; Evans DB; Sharma SK; Mathews WR
    J Neurochem; 2001 Feb; 76(4):1221-32. PubMed ID: 11181841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
    Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cdk5 in the pathogenesis of Alzheimer's disease.
    Lau LF; Ahlijanian MK
    Neurosignals; 2003; 12(4-5):209-14. PubMed ID: 14673207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
    Maccioni RB; Otth C; Concha II; Muñoz JP
    Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an assay to screen for inhibitors of tau phosphorylation by cdk5.
    Ahn JS; Musacchio A; Mapelli M; Ni J; Scinto L; Stein R; Kosik KS; Yeh LA
    J Biomol Screen; 2004 Mar; 9(2):122-31. PubMed ID: 15006135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent roles of GSK3 and CDK5 in APP processing.
    Ryder J; Su Y; Liu F; Li B; Zhou Y; Ni B
    Biochem Biophys Res Commun; 2003 Dec; 312(4):922-9. PubMed ID: 14651959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator.
    Chou KC; Watenpaugh KD; Heinrikson RL
    Biochem Biophys Res Commun; 1999 Jun; 259(2):420-8. PubMed ID: 10362524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.
    Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
    FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.